Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141795 |
| CAS No | NA |
| Mol.F. | C37H52N6O9 |
| Mol.Wt. | 724.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141796 |
| CAS No | NA |
| Mol.F. | C15H9Cl2N3O3 |
| Mol.Wt. | 350.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141797 |
| CAS No | NA |
| Mol.F. | C43H36F2N14O6 |
| Mol.Wt. | 882.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141798 |
| CAS No | NA |
| Mol.F. | C43H37F2N13O5 |
| Mol.Wt. | 853.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141799 |
| CAS No | NA |
| Mol.F. | C21H20FN7O4 |
| Mol.Wt. | 453.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141800 |
| CAS No | NA |
| Mol.F. | C12H7ClN4O5S2 |
| Mol.Wt. | 386.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141801 |
| CAS No | NA |
| Mol.F. | C22H22ClN7O2 |
| Mol.Wt. | 451.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141802 |
| CAS No | NA |
| Mol.F. | C8H12ClN3O2 |
| Mol.Wt. | 217.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141803 |
| CAS No | 53374-52-0 |
| Mol.F. | C8H7N3O2 |
| Mol.Wt. | 177.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141804 |
| CAS No | NA |
| Mol.F. | C19H20Cl2N2O2 |
| Mol.Wt. | 379.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141805 |
| CAS No | NA |
| Mol.F. | C39H58N12O22P2 |
| Mol.Wt. | 1108.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141806 |
| CAS No | NA |
| Mol.F. | C5H2ClN5O |
| Mol.Wt. | 183.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141807 |
| CAS No | 2615274-45-6 |
| Mol.F. | C5H4N6O |
| Mol.Wt. | 164.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141808 |
| CAS No | NA |
| Mol.F. | C17H17N3O7 |
| Mol.Wt. | 375.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141809 |
| CAS No | NA |
| Mol.F. | C35H38N4O7 |
| Mol.Wt. | 626.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141810 |
| CAS No | NA |
| Mol.F. | C19H24N2O2 |
| Mol.Wt. | 312.4 g/mol |
| INV STATUS | In Stock |